 cytometry. HLA or non-HLA specificity will be determined by neutralization of antibody with purified HLA antigens. For the second objective, patients with prior allosensitization will be randomized into 2 groups. 1) Group A will receive HLA matched single donor blood products. 2) Group B will receive random single donor blood
cytometry. HLA or non - HLA specificity will be determined by neutralization of antibody with purified HLA antigens. For the second objective, patient with anterior allosensitization will be randomized into 2 groups. 1) Group A will welcome HLA match single donor blood product. 2) Group B will meet random single donor rake
 cyhometry. HLA or non-HLA sptcificity will be determmned by neutralkzation of antibody with purmfiee HLA antigens. For the secovd objectpve, patiebts xith prior allosxhsitizabnon wjpl bz candomized into 2 groups. 1) Croup A will racdire HLA matched single donor blood prjducts. 2) Ggoup B will reseivt rwndoj single donor blood
cytometry. HLA or non-HLA specificity will be neutralization antibody with HLA antigens. For prior will be randomized 2 groups. 1) A will receive HLA matched single blood products. 2) Group B will receive random single donor blood
 cytometry. HLA or non-HLA speciFicity will Be detErmIneD bY neuTralIzation of antibODy wiTh purified HLA antigens. FOr the SeCOnd oBJeCtive, PatientS WiTH PriOr AlLosEnSItIzatiOn wIll be raNdomized inTo 2 gRoUps. 1) Group A wilL ReCeive HLA maTchEd single donoR blOod proDuCts. 2) gRoup B WilL receIve ranDOm singLe donor blOoD
 cytometry. HLA or non-HLA  specifici ty wi llbede term ined  by neutraliza t ionof antibody with purif ied H LA anti g en s. Fo r the s e co n d  ob je ct ive ,p at ients  wi th prio r allosens iti za tion will be ra ndomized i nto  2 groups. 1 ) G roup A  w ill recei veHLA m atched single  donor bl oo d  produ c ts. 2)G r ou p Bwill receive rand o ms ingle donor bl ood
 cytometry._HLA or_non-HLA specificity will be_determined by_neutralization_of antibody_with_purified HLA antigens._For the second_objective, patients with prior_allosensitization will be_randomized_into 2 groups. 1) Group A will receive HLA matched single donor blood products._2)_Group B_will_receive_random single donor blood